(Q73131045)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11054484%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

title

Long-term effect of IFNbeta1b treatment on the spontaneous and induced expression of IL-10 and TGFbeta1 in MS patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11054484%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11054484%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

author name string

A Gayo

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11054484%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

L Mozo

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11054484%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

A Tuñon

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11054484%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

C Lahoz

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11054484%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

C Gutiérrez

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11054484%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

publication date

1 October 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11054484%20AND%20SRC:MED&resulttype=core&format=json

Journal of the Neurological Sciences

1 November 2019

number of pages

7

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11054484%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

volume

179

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11054484%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

issue

S 1-2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11054484%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

page(s)

43-49

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11054484%20AND%20SRC:MED&resulttype=core&format=json

Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. UBC MS/MRI Study Group and the IFNB Multiple Sclerosis Study Group

1 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900369-5

Interferon beta in multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900369-5

Interferon-beta 1b treatment decreases tumor necrosis factor-alpha and increases interleukin-6 production in multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900369-5

Interferon gamma producing blood lymphocytes are decreased by interferon beta therapy in patients with multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900369-5

Interferon beta decreases T cell activation and interferon gamma production in multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900369-5

Interferon-gamma-secreting cells in multiple sclerosis patients treated with interferon beta-1b

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900369-5

Interferon beta-1b treatment modulates TNFalpha and IFNgamma spontaneous gene expression in MS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900369-5

Interferon beta induces interleukin-10 expression: relevance to multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900369-5

Interferon (IFN)-beta treatment enhances CD95 and interleukin 10 expression but reduces interferon-gamma producing T cells in MS patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900369-5

Immunomodulatory effects of interferon-beta-1b in vivo: induction of the expression of transforming growth factor-beta1 and its receptor type II

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900369-5

Interferon beta-1b effects on cytokine mRNA in peripheral mononuclear cells in multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900369-5

Influence of IFN-beta1b (Betaferon) on cytokine mRNA profiles in blood mononuclear cells and plasma levels of soluble VCAM-1 in multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900369-5

Glucocorticoids increase IL-10 expression in multiple sclerosis patients with acute relapse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900369-5

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900369-5

In vivo effects of interferon beta-1a on immunosuppressive cytokines in multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900369-5

Blood levels of transforming growth factor-beta 1 (TGF-beta1) are elevated in both relapsing remitting and chronic progressive multiple sclerosis (MS) patients and are further augmented by treatment with interferon-beta 1b (IFN-beta1b).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900369-5

10.1016/S0022-510X(00)00369-5

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11054484%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference